Back in 2014, we saw the need for a natural, drug-free and convenient solution to menstrual cramps, which affects over 500 million females around the world. After months of back-breaking product development, our flagship product, MenstruHeat, was born. MenstruHeat is a 100% natural heat therapy patch that can produce 12 hours long lasting heat quickly and steadily.
Since then, MenstruHeat has gone on to “save” thousands of women every month and is now available in more than 400 stores islandwide, including Guardian and 7-Eleven.
Taking everything we’ve learnt along the way in our relentless pursuit for creating the best products, our team of designers, engineers and scientists has completely re-designed MenstruHeat from the ground up.
In February 2017, other than launching the all new design of MenstruHeat, we will be launching BackHeat and NeckHeat to help women with back pains and neck / shoulder pains. Like all products from the pslove company, our 2 newest products are packed full of features and meticulously crafted to meet the needs of women in the modern world.
Overview
Persons 1
| Date | First Name | Last Name | Title | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 26, 2023 | Blood Screening Market Expected to Witness Impressive Growth, Valued at USD 4.77 Billion by 2030-Emergen Research | Emergen Research Logo Rising prevalence of infectious diseases is a key factor driving blood screening market revenue growth VANCOUVER, BRITISH COLUMBIA, CANADA, June 26, 2023/EINPresswire.com/ -- The global blood screening market size was ... |
| Jun 30, 2022 | Blood test startup Aware raises $15m seed round | Blood test health-check platform Aware has emerged from stealth with $15m seed financing in the coffers, as it looks to roll out its private beta to patients in Germany. What does Aware do? Aware is hoping to be a one-stop shop for patients... |
| Mar 12, 2020 | Kymera announces $102 million in new funding to develop treatments for diseases such as blood cancers | Four years after it was founded, Kymera Therapeutics said Thursday that it has now raised more than a quarter-billion dollars from investors keen on its potential approach to treat a range of diseases, including blood cancers. The Cambridge... |
| May 30, 2019 | Johns Hopkins-founded Startup Developing Blood Test to Detect Cancer Raises $110M | A company developing a cancer test that’s designed to be integrated into routine medical care is launching Thursday with the largest funding round for a venture licensing technology from Johns Hopkins. Thrive Earlier Detection Corp., which ... |
| May 30, 2019 | Johns Hopkins-founded startup developing blood test to detect cancer raises $110M | A company developing a cancer test that’s designed to be integrated into routine medical care is launching Thursday with the largest funding round for a venture licensing technology from Johns Hopkins. Thrive Earlier Detection Corp., which ... |
| Oct 26, 2012 | Diagnostics firm with bacteria detection for blood transfusions raising $5 million | Solution/product: Its Pan Genera Detection technology is aimed at detecting bacterial contamination in cells and tissues for blood transfusions and transplantations. Its Platelet PGD Test is the only test approved by the US Food and Drug Ad... |
| Technology to screen blood for bacteria before transfusions raises $12M | Each year, about 13.9 million units of red cells or whole blood are transfused in the U.S. Blood transfusions come with some risks, particularly the danger that the recipient will contract a life threatening illness from contaminated blood.... | |
| Diagnostics firm with bacteria detection for blood transfusions raising $5 million | Company name: Verax Biomedical Industry: Medical devices Location: Worcester, Massachusetts Solution/product: Its Pan Genera Detection technology is aimed at detecting bacterial contamination in cells and tissues for blood transfusions and ... |
Reviews 0
FAQ about pslove
What has the press written about pslove?
Parsers VC has collected 9 articles mentioning pslove, among them “Blood Screening Market Expected to Witness Impressive Growth, Valued at USD 4.77 Billion by 2030-Emergen Research” (Jun 26, 2023) and “Blood test startup Aware raises $15m seed round” (Jun 30, 2022).
Is pslove still active?
Yes, pslove is active; its latest activity on Parsers VC dates from Apr 7, 2026.